1. Home
  2. PPBT vs SPHL Comparison

PPBT vs SPHL Comparison

Compare PPBT & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • SPHL
  • Stock Information
  • Founded
  • PPBT 2010
  • SPHL 2002
  • Country
  • PPBT Israel
  • SPHL Singapore
  • Employees
  • PPBT N/A
  • SPHL N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • SPHL Homebuilding
  • Sector
  • PPBT Health Care
  • SPHL Consumer Discretionary
  • Exchange
  • PPBT Nasdaq
  • SPHL Nasdaq
  • Market Cap
  • PPBT 6.2M
  • SPHL 6.0M
  • IPO Year
  • PPBT N/A
  • SPHL 2024
  • Fundamental
  • Price
  • PPBT $2.31
  • SPHL $0.50
  • Analyst Decision
  • PPBT Strong Buy
  • SPHL
  • Analyst Count
  • PPBT 1
  • SPHL 0
  • Target Price
  • PPBT $33.00
  • SPHL N/A
  • AVG Volume (30 Days)
  • PPBT 269.4K
  • SPHL 99.3K
  • Earning Date
  • PPBT 08-06-2025
  • SPHL 02-21-2025
  • Dividend Yield
  • PPBT N/A
  • SPHL N/A
  • EPS Growth
  • PPBT N/A
  • SPHL N/A
  • EPS
  • PPBT N/A
  • SPHL N/A
  • Revenue
  • PPBT N/A
  • SPHL $6,456,601.00
  • Revenue This Year
  • PPBT N/A
  • SPHL N/A
  • Revenue Next Year
  • PPBT N/A
  • SPHL N/A
  • P/E Ratio
  • PPBT N/A
  • SPHL N/A
  • Revenue Growth
  • PPBT N/A
  • SPHL N/A
  • 52 Week Low
  • PPBT $2.00
  • SPHL $0.35
  • 52 Week High
  • PPBT $13.95
  • SPHL $7.80
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 49.88
  • SPHL N/A
  • Support Level
  • PPBT $2.11
  • SPHL N/A
  • Resistance Level
  • PPBT $2.31
  • SPHL N/A
  • Average True Range (ATR)
  • PPBT 0.16
  • SPHL 0.00
  • MACD
  • PPBT 0.01
  • SPHL 0.00
  • Stochastic Oscillator
  • PPBT 72.73
  • SPHL 0.00

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.

Share on Social Networks: